dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada GLP-1-RA and inhibitors in the management of type 2 diabetes Insights into the Roles of

In a propensity score matching study, there was considerable overlap between the doses of oral semaglutide 7 and 14 mg and sc semaglutide 0.5 and 1.0 mg, respectively [58]

For individuals on GLP-1 diabetes medications who are already struggling with reduced fluid intake, this increased carbohydrate consumption can create additional hydration demands that are difficult to meet through thirst cues alone, potentially leading to dehydration and nutrient deficiencies

L.et al (1996)

"Mechanisms of Action and Therapeutic Application of GLP-1 Receptor Agonists." Cell Metabolism

ESG is a one-time procedure that may offer more durable results and better long-term cost savings